Key Takeaways
- • Pneumonia mortality increased 1 percentage point at private equity-owned hospitals compared to non-PE facilities, representing the first documented link between PE acquisition and worse pulmonary outcomes for this specific condition.
- • COPD readmission rates rose significantly within 30 days of discharge at PE hospitals, indicating both immediate clinical deterioration and potential cost implications for readmission-tied reimbursement models.
- • Broader adverse event pattern confirmed: Prior research documented a 25.4% increase in hospital-acquired adverse events (infections, falls, surgical site infections) post-PE acquisition, with surgical site infections doubling despite reduced surgical volumes.
- • Regulatory gap identified: Researchers at Beth Israel Deaconess Medical Center and the Richard A and Susan F Smith Center for Outcomes Research in Boston flagged insufficient oversight of PE hospital acquisitions, citing conflicts between short-term profit maximization and quality-of-care standards.
- • Market concentration risk: Apollo Global Management controls at least 235 hospital locations across Lifepoint Health and ScionHealth, concentrating significant PE leverage over respiratory care delivery and outcomes.
Summary
New research presented at the American Thoracic Society 2026 conference establishes a direct correlation between private equity ownership and deteriorating patient outcomes for chronic obstructive pulmonary disease (COPD) and pneumonia—conditions affecting millions of hospitalizations annually. The study marks the first rigorous evidence linking PE hospital acquisitions to worse outcomes in these specific respiratory conditions, moving beyond general adverse event tracking to disease-specific mortality and readmission metrics.
Patients hospitalized with pneumonia at PE-owned facilities experienced a 1-percentage-point increase in in-hospital mortality compared to peers treated at non-PE hospitals. For COPD patients, the evidence shows elevated 30-day readmission rates post-discharge, a metric with significant implications for both patient recovery trajectories and hospital reimbursement under value-based care models. Stephen Mein, a pulmonologist at Beth Israel Deaconess Medical Center, stated that the findings "add to growing concerns around the detrimental effects of private equity in healthcare and highlight a critical need for stronger regulations of these acquisitions to protect our patients."
The research aligns with a broader body of evidence on PE hospital acquisition outcomes. Prior studies documented a 25.4% increase in hospital-acquired adverse events following PE acquisition, driven primarily by surges in infections and falls. Notably, surgical site infections doubled from 10.8 to 21.6 per 10,000 hospitalizations at PE hospitals despite an 8.1% reduction in surgical volume, suggesting quality degradation rather than volume-driven complications. These patterns point toward cost-cutting measures—potentially including staffing reductions, supply chain optimization, and operational consolidation—that may compromise clinical vigilance and infection control protocols.
The implications extend to market structure and concentration risk. Apollo Global Management operates at least 235 hospital locations through Lifepoint Health and ScionHealth, establishing significant control over respiratory and critical care delivery. As private equity acquisition of US hospitals accelerates, performance disparities between PE and traditional hospital operators create measurable clinical and financial consequences, particularly for chronic disease management where compliance, monitoring, and readmission prevention are economically and clinically central. The research reinforces calls for enhanced regulatory scrutiny of PE healthcare acquisitions before transactions close, rather than retrospective quality audits.
Patients hospitalized with pneumonia at PE-owned facilities experienced a 1-percentage-point increase in in-hospital mortality compared to peers treated at non-PE hospitals. For COPD patients, the evidence shows elevated 30-day readmission rates post-discharge, a metric with significant implications for both patient recovery trajectories and hospital reimbursement under value-based care models. Stephen Mein, a pulmonologist at Beth Israel Deaconess Medical Center, stated that the findings "add to growing concerns around the detrimental effects of private equity in healthcare and highlight a critical need for stronger regulations of these acquisitions to protect our patients."
The research aligns with a broader body of evidence on PE hospital acquisition outcomes. Prior studies documented a 25.4% increase in hospital-acquired adverse events following PE acquisition, driven primarily by surges in infections and falls. Notably, surgical site infections doubled from 10.8 to 21.6 per 10,000 hospitalizations at PE hospitals despite an 8.1% reduction in surgical volume, suggesting quality degradation rather than volume-driven complications. These patterns point toward cost-cutting measures—potentially including staffing reductions, supply chain optimization, and operational consolidation—that may compromise clinical vigilance and infection control protocols.
The implications extend to market structure and concentration risk. Apollo Global Management operates at least 235 hospital locations through Lifepoint Health and ScionHealth, establishing significant control over respiratory and critical care delivery. As private equity acquisition of US hospitals accelerates, performance disparities between PE and traditional hospital operators create measurable clinical and financial consequences, particularly for chronic disease management where compliance, monitoring, and readmission prevention are economically and clinically central. The research reinforces calls for enhanced regulatory scrutiny of PE healthcare acquisitions before transactions close, rather than retrospective quality audits.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.